Compare, Analyse Dr. Reddys with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs MYLAN (US) - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   MYLAN
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
MYLAN
Dec-18
DR. REDDYS LAB/
MYLAN
5-Yr Chart
Click to enlarge
High Rs2,8753,395-   
Low Rs1,8881,869-   
Sales per share (Unadj.) Rs930.21,562.1-  
Earnings per share (Unadj.) Rs117.442.4-  
Cash flow per share (Unadj.) Rs185.8334.9-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs844.41,689.9-  
Shares outstanding (eoy) m166.07514.50-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.61.7 152.0%   
Avg P/E ratio x20.362.0 32.7%  
P/CF ratio (eoy) x12.87.9 163.2%  
Price / Book Value ratio x2.81.6 181.1%  
Dividend payout %17.00-   
Avg Mkt Cap Rs m395,4961,354,014 29.2%   
No. of employees `00022.035.0 62.8%   
Total wages/salary Rs m33,5620-   
Avg. sales/employee Rs Th7,032.822,963.0 30.6%   
Avg. wages/employee Rs Th1,527.90-   
Avg. net profit/employee Rs Th887.7623.5 142.4%   
INCOME DATA
Net Sales Rs m154,482803,705 19.2%  
Other income Rs m3,3750-   
Total revenues Rs m157,857803,705 19.6%   
Gross profit Rs m31,782207,969 15.3%  
Depreciation Rs m11,348150,485 7.5%   
Interest Rs m88938,655 2.3%   
Profit before tax Rs m22,92018,828 121.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,858-2,995 -128.8%   
Profit after tax Rs m19,50021,824 89.4%  
Gross profit margin %20.625.9 79.5%  
Effective tax rate %16.8-15.9 -105.8%   
Net profit margin %12.62.7 464.9%  
BALANCE SHEET DATA
Current assets Rs m111,101448,788 24.8%   
Current liabilities Rs m58,973327,216 18.0%   
Net working cap to sales %33.715.1 223.1%  
Current ratio x1.91.4 137.4%  
Inventory Days Days7984 94.9%  
Debtors Days Days9493 100.9%  
Net fixed assets Rs m101,245155,906 64.9%   
Share capital Rs m830428 194.0%   
"Free" reserves Rs m139,4060-   
Net worth Rs m140,236869,462 16.1%   
Long term debt Rs m22,000938,429 2.3%   
Total assets Rs m224,6562,332,235 9.6%  
Interest coverage x26.81.5 1,801.0%   
Debt to equity ratio x0.21.1 14.5%  
Sales to assets ratio x0.70.3 199.5%   
Return on assets %9.12.6 350.0%  
Return on equity %13.92.5 554.0%  
Return on capital %14.93.2 470.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m69,5690-   
CASH FLOW
From Operations Rs m28,704167,010 17.2%  
From Investments Rs m-7,727-86,326 9.0%  
From Financial Activity Rs m-21,326-77,803 27.4%  
Net Cashflow Rs m-3141,384 -22.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.32 Rs / USD

Compare DR. REDDYS LAB With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare DR. REDDYS LAB With: CIPLA  AJANTA PHARMA  SUVEN LIFESCIENCES  AUROBINDO PHARMA  FDC LTD.  



Today's Market

Indian Indices Witness Huge Selling; Sensex Ends 458 Points Lower(Closing)

After opening on a negative note in the morning trade today, India share markets witnessed further selling and ended their session deep in the red.

Related Views On News

THYROCARE TECHNOLOGIES Surges by 7%; BSE HEALTHCARE Index Up 1.8% (Market Updates)

Jan 27, 2020 | Updated on Jan 27, 2020

THYROCARE TECHNOLOGIES share price has surged by 7% and its current market price is Rs 587. The BSE HEALTHCARE is up by 1.8%. The top gainers in the BSE HEALTHCARE Index are THYROCARE TECHNOLOGIES (up 6.6%) and DR. REDDYS LAB (up 5.4%). The top losers are CADILA HEALTHCARE and J.B.CHEMICALS (down 0.3%).

DR. REDDYS LAB at 52 Week High; BSE 500 Index Down 0.1 % (Market Updates)

Jan 27, 2020 | Updated on Jan 27, 2020

DR. REDDYS LAB share price has hit a 52-week high. It is presently trading at Rs 3,111. BSE 500 Index is down by 0.1% at 16,005. Within the BSE 500, DR. REDDYS LAB (up 2.4%) and EDELWEISS FINANCIAL (up 9.7%) are among the top gainers, while top losers are JET AIRWAYS and MANPASAND BEVERAGES.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

Bet on These Smallcap Stocks for Success in 2020 (Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex (Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

How to Buy the Best Safe Stocks in 2020 (The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market (Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys (The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Guide on How to Profit from Sensex 100,000.
A Simple Test to Find out If a Stock Has 100x Potential
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Revealed: Top 7 Stocks to Consider Buying Right Now...

DR. REDDYS LAB SHARE PRICE


Jan 27, 2020 03:33 PM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

OTHER USEFUL LINKS

MARKET STATS